Doubler score 60 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
DDOGDatadog+5.4%
Doubler score 63 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
SLNSilence Therapeutics+125.6%
Doubler score 74 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
PLTRPalantir Technologies+4.4%
Doubler score 72 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
MRNAModerna+4.1%
Doubler score 76 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased
MRVLMarvell Technology+4.1%
Doubler score 64 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
CLFCleveland-Cliffs+16.3%
Doubler score 70 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades